These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22796229)

  • 1. Meta-analysis of increased heart rate and blood pressure associated with CNS stimulant treatment of ADHD in adults.
    Mick E; McManus DD; Goldberg RJ
    Eur Neuropsychopharmacol; 2013 Jun; 23(6):534-41. PubMed ID: 22796229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder.
    Wilens TE; Hammerness PG; Biederman J; Kwon A; Spencer TJ; Clark S; Scott M; Podolski A; Ditterline JW; Morris MC; Moore H
    J Clin Psychiatry; 2005 Feb; 66(2):253-9. PubMed ID: 15705013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder.
    Martinez-Raga J; Knecht C; Szerman N; Martinez MI
    CNS Drugs; 2013 Jan; 27(1):15-30. PubMed ID: 23160939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHD.
    Weisler RH; Biederman J; Spencer TJ; Wilens TE
    CNS Spectr; 2005 Dec; 10(12 Suppl 20):35-43. PubMed ID: 16344839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD.
    Vitiello B; Elliott GR; Swanson JM; Arnold LE; Hechtman L; Abikoff H; Molina BS; Wells K; Wigal T; Jensen PS; Greenhill LL; Kaltman JR; Severe JB; Odbert C; Hur K; Gibbons R
    Am J Psychiatry; 2012 Feb; 169(2):167-77. PubMed ID: 21890793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
    Faraone SV; Glatt SJ
    J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects of Long-Acting Stimulant and Nonstimulant Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials.
    Cerrillo-Urbina AJ; García-Hermoso A; Pardo-Guijarro MJ; Sánchez-López M; Santos-Gómez JL; Martínez-Vizcaíno V
    J Child Adolesc Psychopharmacol; 2018 Oct; 28(8):494-507. PubMed ID: 29897263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does prior exposure to stimulants in children with ADHD impact cardiovascular parameters from lisdexamfetamine dimesylate?
    Wigal SB; Jun A; Wong AA; Stehli A; Steinberg-Epstein R; Lerner MA
    Postgrad Med; 2010 Sep; 122(5):27-34. PubMed ID: 20861585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Epstein T; Patsopoulos NA; Weiser M
    Cochrane Database Syst Rev; 2014 Sep; (9):CD005041. PubMed ID: 25230710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADHD pharmacotherapy: rates of stimulant use and cardiovascular risk.
    Kratochvil CJ
    Am J Psychiatry; 2012 Feb; 169(2):112-4. PubMed ID: 22318789
    [No Abstract]   [Full Text] [Related]  

  • 11. Adult attention-deficit/hyperactivity disorder treatment and cardiovascular implications.
    Hammerness PG; Surman CB; Chilton A
    Curr Psychiatry Rep; 2011 Oct; 13(5):357-63. PubMed ID: 21698412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term effects of lisdexamfetamine dimesylate on cardiovascular parameters in a 4-week clinical trial in adults with attention-deficit/hyperactivity disorder.
    Adler LA; Weisler RH; Goodman DW; Hamdani M; Niebler GE
    J Clin Psychiatry; 2009 Dec; 70(12):1652-61. PubMed ID: 20141706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the effect of ADHD stimulant medication on heart rate and blood pressure in a community sample of children?
    St Amour MD; O'Leary DD; Cairney J; Wade TJ
    Can J Public Health; 2018 Jun; 109(3):395-400. PubMed ID: 29981090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.
    Verbeeck W; Bekkering GE; Van den Noortgate W; Kramers C
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009504. PubMed ID: 28965364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiovascular risks and management during Attention Deficit Hyperactivity Disorder treatment with methylphenidate].
    Bange F; Le Heuzey MF; Acquaviva E; Delorme R; Mouren MC
    Arch Pediatr; 2014 Jan; 21(1):108-12. PubMed ID: 24309201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulant therapy in children with attention-deficit/hyperactivity disorder and concomitant long QT syndrome: A safe combination?
    Rohatgi RK; Bos JM; Ackerman MJ
    Heart Rhythm; 2015 Aug; 12(8):1807-12. PubMed ID: 25956966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular safety of stimulant medications for pediatric attention-deficit hyperactivity disorder.
    Silva RR; Skimming JW; Muniz R
    Clin Pediatr (Phila); 2010 Sep; 49(9):840-51. PubMed ID: 20693523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled study of autonomic nervous system function in adults with attention-deficit/hyperactivity disorder treated with stimulant medications: results of a pilot study.
    Schubiner H; Hassunizadeh B; Kaczynski R
    J Atten Disord; 2006 Nov; 10(2):205-11. PubMed ID: 17085631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults.
    Santosh PJ; Sattar S; Canagaratnam M
    CNS Drugs; 2011 Sep; 25(9):737-63. PubMed ID: 21870887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and Long-Term Cardiovascular Effects of Stimulant, Guanfacine, and Combination Therapy for Attention-Deficit/Hyperactivity Disorder.
    Sayer GR; McGough JJ; Levitt J; Cowen J; Sturm A; Castelo E; McCracken JT
    J Child Adolesc Psychopharmacol; 2016 Dec; 26(10):882-888. PubMed ID: 27483130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.